One of the mechanisms through which the coagulation pathway is affected is that patients with cirrhosis have variable degrees of thrombocytopenia, which is due to increased platelet destruction, increased splenic and hepatic sequestration, and decreased levels of thrombopoietin. This evidence concerns the gene THPO and Cirrhosis.